BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37733171)

  • 1. Pediatric acute myeloid leukemia and hyperleukocytosis with WBC count greater than 50 × 10
    Zhang A; Liu L; Zong S; Chang L; Chen X; Yang W; Guo Y; Zhang L; Zou Y; Chen Y; Zhang Y; Ruan M; Zhu X
    Int J Hematol; 2023 Dec; 118(6):737-744. PubMed ID: 37733171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperleukocytosis predicts inferior clinical outcome in pediatric acute myeloid leukemia.
    Xu LH; Wang JW; Wang Y; Yang FY
    Hematology; 2020 Dec; 25(1):507-514. PubMed ID: 33317436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long term impact of hyperleukocytosis in newly diagnosed acute myeloid leukemia patients undergoing allogeneic stem cell transplantation: An analysis from the acute leukemia working party of the EBMT.
    Canaani J; Labopin M; Socié G; Nihtinen A; Huynh A; Cornelissen J; Deconinck E; Gedde-Dahl T; Forcade E; Chevallier P; Bourhis JH; Blaise D; Mohty M; Nagler A
    Am J Hematol; 2017 Jul; 92(7):653-659. PubMed ID: 28370339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukapheresis in acute myeloid leukemia patients with hyperleukocytosis: A single center experience.
    Berber I; Kuku I; Erkurt MA; Kaya E; Bag HG; Nizam I; Koroglu M; Ozgul M; Bazna S
    Transfus Apher Sci; 2015 Oct; 53(2):185-90. PubMed ID: 25843763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minimally early morbidity in children with acute myeloid leukemia and hyperleukocytosis treated with prompt chemotherapy without leukapheresis.
    Chen KH; Liu HC; Liang DC; Hou JY; Huang TH; Chang CY; Yeh TC
    J Formos Med Assoc; 2014 Nov; 113(11):833-8. PubMed ID: 24534017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Long-term outcomes of homoharringtonine, cytarabine, daunorubicin or idarubicin (HAD/HAI) as induction chemotherapy in de novo acute myeloid leukemia].
    Qin T; Xu Z; Zhang Y; Lin Y; Ru K; Fang L; Zhang H; Pan L; Hu N; Qu S; Wang J; Xing R; Xiao Z
    Zhonghua Xue Ye Xue Za Zhi; 2016 Feb; 37(2):94-9. PubMed ID: 27014976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and biologic features and treatment outcome of children with newly diagnosed acute myeloid leukemia and hyperleukocytosis.
    Inaba H; Fan Y; Pounds S; Geiger TL; Rubnitz JE; Ribeiro RC; Pui CH; Razzouk BI
    Cancer; 2008 Aug; 113(3):522-9. PubMed ID: 18484648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of acute myeloid leukemia patients with hyperleukocytosis in Brazil.
    Oliveira LC; Romano LG; Prado-Junior BP; Covas DT; Rego EM; De Santis GC
    Med Oncol; 2010 Dec; 27(4):1254-9. PubMed ID: 19937404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment Outcome in Pediatric Acute Lymphoblastic Leukemia With Hyperleukocytosis in the Yeungnam Region of Korea: A Multicenter Retrospective Study.
    Park KM; Yang EJ; Lee JM; Hah JO; Park SK; Park ES; Lim JY; Kim JY; Park J; Shim YJ; Kong SG; Lim YT
    J Pediatr Hematol Oncol; 2020 May; 42(4):275-280. PubMed ID: 32134842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics and prognosis analysis of patients with de novo ASXL1-mutated AML treated with the C-HUNAN-AML-15 protocol: A multicenter study by the South China Pediatric AML Collaborative Group.
    Zeng M; Chen K; Tian X; Zou R; Feng X; Li C; Li J; Zheng M; Mai H; Yang L; He Y; Xu H; Wen H; He X
    Cancer Med; 2023 Jun; 12(12):13182-13192. PubMed ID: 37132266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Characteristics and Prognosis of 24 Cases of Primary Acute Myeloid Leukemia with Trisomy 8].
    Wang JH; Yao B; Guo M; Qiao JH; Sun QY; Hu KX; Li BX; Yu CL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Jun; 24(3):655-61. PubMed ID: 27342486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics and outcomes of children with newly diagnosed acute myeloid leukemia and hyperleukocytosis managed with different cytoreductive methods.
    Christakopoulos GE; Walker KN; Smith J; Takemoto CM; Zheng Y; Pui CH; Ribeiro RC; Wang L; Pounds SB; Rubnitz JE; Inaba H
    Cancer; 2023 Jun; 129(12):1873-1884. PubMed ID: 36943896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of pre-induction therapy leukapheresis on treatment outcome in adult acute myelogenous leukemia presenting with hyperleukocytosis.
    Thiébaut A; Thomas X; Belhabri A; Anglaret B; Archimbaud E
    Ann Hematol; 2000 Sep; 79(9):501-6. PubMed ID: 11043421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [244 patients with hyperleukocytic acute leukemia. Shanghai Leukemia Cooperation Group].
    Wang X; Lin G; Wang J
    Zhonghua Nei Ke Za Zhi; 1997 Aug; 36(8):532-5. PubMed ID: 10436959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic leukocytapheresis in infants and children with leukemia and hyperleukocytosis: A single institution experience.
    Thapa N; Pham R; Cole C; Meinershagen M; Bowman PW; Ray A
    J Clin Apher; 2018 Jun; 33(3):316-323. PubMed ID: 29193219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of leukapheresis on early death rate in adult acute myeloid leukemia presenting with hyperleukocytosis.
    Bug G; Anargyrou K; Tonn T; Bialleck H; Seifried E; Hoelzer D; Ottmann OG
    Transfusion; 2007 Oct; 47(10):1843-50. PubMed ID: 17880610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxemia During Extreme Hyperleukocytosis: How Spurious?
    Van de Louw A; Desai RJ; Schneider CW; Claxton DF
    Respir Care; 2016 Jan; 61(1):8-14. PubMed ID: 26420901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukapheresis and exchange transfusion in children with acute leukemia and hyperleukocytosis. A single center experience.
    Haase R; Merkel N; Diwan O; Elsner K; Kramm CM
    Klin Padiatr; 2009; 221(6):374-8. PubMed ID: 19890790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early Complications of Hyperleukocytosis and Leukapheresis in Childhood Acute Leukemias.
    Abla O; Angelini P; Di Giuseppe G; Kanani MF; Lau W; Hitzler J; Sung L; Naqvi A
    J Pediatr Hematol Oncol; 2016 Mar; 38(2):111-7. PubMed ID: 26794706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD34 expression predicts an adverse outcome in patients with NPM1-positive acute myeloid leukemia.
    Dang H; Chen Y; Kamel-Reid S; Brandwein J; Chang H
    Hum Pathol; 2013 Oct; 44(10):2038-46. PubMed ID: 23701943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.